Jevtana (cabazitaxel) Injection Approved by U.S. FDA After Priority Review

Paris, France – June 17, 2010 – Sanofi-aventis announced
today that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for
Jevtana (cabazitaxel) Injection in combination with prednisone for the treatment of...

...

More on Sciencestage.com